5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation
    Journal Article

    Warrick, J. I.; Hu, W.; Yamashita, H.; Walter, V.; Shuman, L.; Craig, J. M.; Gellert, L. L.; Castro, M. A. A.; Robertson, A. G.; Kuo, F.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancer
    Journal Article

    Zhao, S. G.; Sperger, J. M.; Schehr, J. L.; McKay, R. R.; Emamekhoo, H.; Singh, A.; Schultz, Z. D.; Bade, R. M.; Stahlfeld, C. N.; Gilsdorf, C. S.; more...
    Journal of Clinical Investigation (2022)

    Fulltext@MSK | Save
  • FRACTION-RCC: Nivolumab plus ipilimumab for advanced renal cell carcinoma after progression on immuno-oncology therapy
    Journal Article

    Choueiri, T. K.; Kluger, H.; George, S.; Tykodi, S. S.; Kuzel, T. M.; Perets, R.; Nair, S.; Procopio, G.; Carducci, M. A.; Castonguay, V.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • IRONMAN: A novel international registry of men with advanced prostate cancer
    Journal Article

    Mucci, L. A.; Vinson, J.; Gold, T.; Gerke, T.; Filipenko, J.; Green, R. M.; Anderson, S. G.; Badal, S.; Bjartell, A.; Chi, K. N.; more...
    JCO Global Oncology (2022)

    Fulltext@MSK | Save
  • Nivolumab plus ipilimumab plus cabozantinib triplet combination for patients with previously untreated advanced renal cell carcinoma: Results from a discontinued arm of the phase III CheckMate 9ER trial
    Journal Article

    Apolo, A. B.; Powles, T.; Escudier, B.; Burotto, M.; Zhang, J.; Simsek, B.; Scheffold, C.; Motzer, R. J.; Choueiri, T. K.
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • XL-ing at induction of apoptosis in kidney cancer through inhibition of BCL-X(L)
    Editorial

    Wang, N.; Hakimi, A. A.; Chen, Y.
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Genetic ancestry correlates with somatic differences in a real-world clinical cancer sequencing cohort
    Journal Article

    Arora, K.; Tran, T. N.; Kemel, Y.; Mehine, M.; Liu, Y. L.; Nandakumar, S.; Smith, S. A.; Brannon, A. R.; Ostrovnaya, I.; Stopsack, K. H.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Efficacy and safety of telaglenastat plus cabozantinib vs placebo plus cabozantinib in patients with advanced renal cell carcinoma: The CANTATA randomized clinical trial
    Journal Article

    Tannir, N. M.; Agarwal, N.; Porta, C.; Lawrence, N. J.; Motzer, R.; McGregor, B.; Lee, R. J.; Jain, R. K.; Davis, N.; Appleman, L. J.; more...
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • Lineage plasticity in prostate cancer depends on FGFR and JAK/STAT inflammatory signaling
    Meeting Abstract

    Chan, J.; Zaidi, S.; Love, J.; Zhao, J.; Setty, M.; Wadosky, K.; Gopalan, A.; Choo, Z. N.; Persad, S.; Chaudhary, O.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • HER2 as a therapeutic target in bladder cancer
    Meeting Abstract

    Chen, Z.; Tang, X.; Christin, J. R.; Gao, S. P.; Chu, C. E.; Berger, M. F.; Schultz, N. D.; Shen, M. M.; Al-Ahmadie, H. A.; Iyer, G.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save